8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors3,815 citations

Radiat Res 147(4):495-500, 1997

Bioeffects Seen

Authors not listed · 1997

Share:

Head and neck cancer research focuses on traditional risk factors while largely ignoring EMF exposure to these same vulnerable tissues.

Plain English Summary

Summary written for general audiences

This 2020 comprehensive review examined head and neck squamous cell carcinoma (HNSCC), a cancer affecting the mouth, throat, and voice box areas. The study found that while tobacco and alcohol remain major risk factors, human papillomavirus (HPV) infections are increasingly driving these cancers, particularly in the throat region. This matters because understanding cancer mechanisms helps identify all potential contributing factors, including environmental exposures.

Why This Matters

While this review focuses on established cancer risk factors like tobacco, alcohol, and HPV, it highlights a crucial gap in our understanding of head and neck cancers. The reality is that cell phones are held directly against these same anatomical regions for hours daily, yet electromagnetic field exposure receives minimal attention in mainstream cancer research. The science demonstrates that RF radiation can penetrate several centimeters into head and neck tissues, the exact areas where these cancers develop. What this means for you is that comprehensive cancer prevention strategies should consider all potential risk factors, not just the traditional ones. The evidence shows we need more research examining whether chronic EMF exposure to head and neck tissues contributes to the rising cancer rates in these regions, especially among younger populations who have used wireless devices throughout their lives.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (1997). Radiat Res 147(4):495-500, 1997.
Show BibTeX
@article{radiat_res_1474495_500_1997_ce3077,
  author = {Unknown},
  title = {Radiat Res 147(4):495-500, 1997},
  year = {1997},
  doi = {10.1038/s41572-020-00224-3},
  
}
DOI: 10.1038/s41572-020-00224-3PubMed: 33243986

Quick Questions About This Study

Head and neck squamous cell carcinoma primarily affects the mucosal lining of the oral cavity, pharynx (throat), and larynx (voice box). These are the same tissue regions that receive direct electromagnetic field exposure from cell phones during calls.
HPV infection is increasingly responsible for pharynx cancers, while tobacco and alcohol remain primary causes for oral cavity and larynx cancers. This shift has created two distinct disease categories: HPV-positive and HPV-negative head and neck cancers.
Despite evidence of cellular changes progressing through various stages of abnormality, most patients are diagnosed with advanced-stage disease without clinically obvious pre-cancerous lesions. Early detection remains challenging in these anatomical regions.
Treatment typically involves multiple approaches: surgery followed by combined chemotherapy and radiation for oral cancers, and primary chemoradiotherapy for throat and voice box cancers. Newer immunotherapy drugs are also approved for advanced cases.
The past decade of genetic research has revealed new therapeutic targets and led to FDA approval of immune checkpoint inhibitors like pembrolizumab and nivolumab. Scientists are working to identify biomarkers for more personalized, effective treatments.